Len+DEB-TACE

COMBINATION_PRODUCT2 trials

Sponsors

Second Affiliated Hospital of Guangzhou Medical University

Conditions

Hepatocellular Carcinoma Non-resectable

Phase 3

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

RecruitingNCT06492395

Second Affiliated Hospital of Guangzhou Medical UniversityHepatocellular Carcinoma Non-resectable

Start: 2024-08-01End: 2027-07-31Target: 178Updated: 2025-01-29

Unknown Phase

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

CompletedNCT06265883

Second Affiliated Hospital of Guangzhou Medical UniversityHepatocellular Carcinoma Non-resectable

Start: 2019-07-01End: 2022-12-31Updated: 2024-02-20